Autopsy report · NCT02794467
Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis
Cause of deathFunding or business, also regulatory or ethics
“Study was prematurely discontinued due to GSK's change in prioritization for the portfolio and is not due to any safety concerns or regulatory interaction.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- GlaxoSmithKline
- Sponsor type
- Industry
- Conditions
- Adenomyosis
- Interventions
- Epelsiban; Placebo
- Participants
- 0
- Sites
- 13
- Countries
- United States
Trials that died the same way
- Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
“The study was terminated due to a change in GSK's R\&D priorities.” - A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD
“The study was discontinued due to a business decision; no safety concerns were noted.” - Efficacy Comparison of Dostarlimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)
“Trial terminated by GSK for strategic reasons, after all participants completed treatment. This decision was not based on a safety concern” - Pre-operative Mocetinostat (MGCD0103) and Durvalumab (MEDI4736) (PRIMED) for Squamous Cell Carcinoma of the Oral Cavity
“The study has been terminated due to a change in internal prioritization and not due to any safety concerns.” - A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients
“The study has been early terminated due to business reasons. This decision is not related to any safety, efficacy, or regulatory concerns.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.